Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 28363-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- MAEA antibody
- Antibody type
- Polyclonal
- Description
- MAEA antibody (Cat. #28363-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Proteome-wide C-degron activity profiling connects conditional regulation of the CTLH E3 ligase complex to ribosome biogenesis.
The E3 ubiquitin ligase MAEA promotes macrophage phagocytosis and inhibits gastrointestinal cancer progression by mediating PARP1 ubiquitination and degradation.
mTORC1 regulates the pyrimidine salvage pathway by controlling UCK2 turnover via the CTLH-WDR26 E3 ligase.
mTORC1-CTLH E3 ligase regulates the degradation of HMG-CoA synthase 1 through the Pro/N-degron pathway.
LAD1 promotes malignant progression by diminishing ubiquitin-dependent degradation of vimentin in gastric cancer.
Identifying E3 Ligase Substrates With Quantitative Degradation Proteomics.
E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression.
Oncopeptide MBOP Encoded by LINC01234 Promotes Colorectal Cancer through MAPK Signaling Pathway.
Grant DW, Tan S, Ramage DE, Li MZ, Di Y, Tchasovnikarova IA, Weekes MP, Elledge SJ, Warren AJ, Timms RT
bioRxiv : the preprint server for biology 2026 Jan 14;
bioRxiv : the preprint server for biology 2026 Jan 14;
The E3 ubiquitin ligase MAEA promotes macrophage phagocytosis and inhibits gastrointestinal cancer progression by mediating PARP1 ubiquitination and degradation.
Feng Y, Zou X, Huang J, Huang Z, Kuang G, Jiang Y
International journal of biological sciences 2025;21(4):1784-1800
International journal of biological sciences 2025;21(4):1784-1800
mTORC1 regulates the pyrimidine salvage pathway by controlling UCK2 turnover via the CTLH-WDR26 E3 ligase.
Pham BQ, Yi SA, Ordureau A, An H
Cell reports 2025 Jan 28;44(1):115179
Cell reports 2025 Jan 28;44(1):115179
mTORC1-CTLH E3 ligase regulates the degradation of HMG-CoA synthase 1 through the Pro/N-degron pathway.
Yi SA, Sepic S, Schulman BA, Ordureau A, An H
Molecular cell 2024 Jun 6;84(11):2166-2184.e9
Molecular cell 2024 Jun 6;84(11):2166-2184.e9
LAD1 promotes malignant progression by diminishing ubiquitin-dependent degradation of vimentin in gastric cancer.
Jiang Y, Feng Y, Huang J, Huang Z, Tan R, Li T, Chen Z, Tang X, Qiu J, Li C, Chen H, Yang Z
Journal of translational medicine 2023 Sep 17;21(1):632
Journal of translational medicine 2023 Sep 17;21(1):632
Identifying E3 Ligase Substrates With Quantitative Degradation Proteomics.
Jordan VN, Ordureau A, An H
Chembiochem : a European journal of chemical biology 2023 Aug 15;24(16):e202300108
Chembiochem : a European journal of chemical biology 2023 Aug 15;24(16):e202300108
E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression.
Zhou P, Peng X, Tang S, Zhang K, Tan Z, Li D, Shen L, Peng J, Yang L
Oncogene 2023 Apr;42(16):1308-1320
Oncogene 2023 Apr;42(16):1308-1320
Oncopeptide MBOP Encoded by LINC01234 Promotes Colorectal Cancer through MAPK Signaling Pathway.
Tang C, Zhou Y, Sun W, Hu H, Liu Y, Chen L, Ou F, Zeng S, Lin N, Yu L
Cancers 2022 May 9;14(9)
Cancers 2022 May 9;14(9)
No comments: Submit comment
No validations: Submit validation data